428
Views
48
CrossRef citations to date
0
Altmetric
Original Articles

Causes of Death Among Patients With Chronic Fatigue Syndrome

, , , &
Pages 615-626 | Received 16 Dec 2004, Accepted 16 Mar 2005, Published online: 23 Feb 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Meghan K. Elliott & Leonard A. Jason. (2023) Risk factors for suicidal ideation in a chronic illness. Death Studies 47:7, pages 827-835.
Read now
Madeline L. Johnson, Joseph Cotler, Julia M. Terman & Leonard A. Jason. (2022) Risk factors for suicide in chronic fatigue syndrome. Death Studies 46:3, pages 738-744.
Read now
Cathy L. Pederson, Kathleen Gorman-Ezell, Greta Hochstetler Mayer & Jeffrey B. Brookings. (2021) Development and Preliminary Validation of a Tool for Screening Suicide Risk in Chronically Ill Women. Measurement and Evaluation in Counseling and Development 54:2, pages 130-140.
Read now
Shu Cai, Hong Lin, Xuan Hu, Yue-Xiu Cai, Ken Chen & Wen-Zhi Cai. (2018) High fatigue and its associations with health and work related factors among female medical personnel at 54 hospitals in Zhuhai, China. Psychology, Health & Medicine 23:3, pages 304-316.
Read now
Cathy Lynn Pederson & Jill Blettner Brook. (2017) Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome. Nature and Science of Sleep 9, pages 109-115.
Read now
Stephanie L. McManimen, Andrew R. Devendorf, Abigail A. Brown, Billie C. Moore, James H. Moore & Leonard A. Jason. (2016) Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome. Fatigue: Biomedicine, Health & Behavior 4:4, pages 195-207.
Read now
William M Mitchell. (2016) Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Expert Review of Clinical Pharmacology 9:6, pages 755-770.
Read now
Chi-Un Pae, David M Marks, Ashwin A Patkar, Prakash S Masand, Patrick Luyten & Alessandro Serretti. (2009) Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opinion on Pharmacotherapy 10:10, pages 1561-1570.
Read now

Articles from other publishers (39)

Jean M. Nunes, Douglas B. Kell & Etheresia Pretorius. (2023) Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses. Blood Reviews 60, pages 101075.
Crossref
Miriam Kristine Sandvik, Kari Sørland, Elisabeth Leirgul, Ingrid Gurvin Rekeland, Christina Særsten Stavland, Olav Mella & Øystein Fluge. (2023) Endothelial dysfunction in ME/CFS patients. PLOS ONE 18:2, pages e0280942.
Crossref
Alaa Ghali, Carole Lacout, Jacques-Olivier Fortrat, Karine Depres, Maria Ghali & Christian Lavigne. (2022) Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics 12:10, pages 2540.
Crossref
Nancy J. Muller. 2022. Research Anthology on Approaches to Social and Sustainable Entrepreneurship. Research Anthology on Approaches to Social and Sustainable Entrepreneurship 395 419 .
Mohammad Moshawrab, Mehdi Adda, Abdenour Bouzouane, Hussein Ibrahim & Ali Raad. (2022) Smart Wearables for the Detection of Occupational Physical Fatigue: A Literature Review. Sensors 22:19, pages 7472.
Crossref
Michael Maes, Marta Kubera & Magdalena Kotańska. (2022) Aberrations in the Cross-Talks Among Redox, Nuclear Factor-κB, and Wnt/β-Catenin Pathway Signaling Underpin Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Frontiers in Psychiatry 13.
Crossref
Mona Dehhaghi, Hamed Kazemi Shariat Panahi, Bahar Kavyani, Benjamin Heng, Vanessa Tan, Nady Braidy & Gilles J. Guillemin. (2022) The Role of Kynurenine Pathway and NAD + Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome . Aging and disease 13:3, pages 698.
Crossref
Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, Nicolas Garcia & Aintzane Zabaleta. (2021) Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Frontiers in Immunology 12.
Crossref
Stanley Du Preez, Helene Cabanas, Donald Staines & Sonya Marshall-Gradisnik. (2021) Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review. International Journal of Environmental Research and Public Health 18:20, pages 10708.
Crossref
Keng Hng, Keith Geraghty & Derek Pheby. (2021) An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis. Medicina 57:9, pages 885.
Crossref
Lily Chu, Meghan Elliott, Eleanor Stein & Leonard A. Jason. (2021) Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare 9:6, pages 629.
Crossref
Patricia A. Fennell, Nancy Dorr & Shane S. George. (2021) Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected. Healthcare 9:5, pages 553.
Crossref
So-Hyun Ahn, Jeong Lan Kim, Jang Rae Kim, So Hee Lee, Hyeon Woo Yim, Hyunsuk Jeong, Jeong-Ho Chae, Hye Yoon Park, Jung Jae Lee & Haewoo Lee. (2021) Association between chronic fatigue syndrome and suicidality among survivors of Middle East respiratory syndrome over a 2-year follow-up period. Journal of Psychiatric Research 137, pages 1-6.
Crossref
Nancy J. Muller. 2021. Handbook of Research on Innate Leadership Characteristics and Examinations of Successful First-Time Leaders. Handbook of Research on Innate Leadership Characteristics and Examinations of Successful First-Time Leaders 319 343 .
Mei-Lin Zhang, Hong-Juan Fu, Yong Tang, Zhen-Guo Luo, Jian-Yong Li & Rui Li. (2021) Effect of acupoint catgut embedding in chronic fatigue syndrome patients. Medicine 100:5, pages e23946.
Crossref
Andrew R Devendorf, Stephanie L McManimen & Leonard A Jason. (2018) Suicidal ideation in non-depressed individuals: The effects of a chronic, misunderstood illness. Journal of Health Psychology 25:13-14, pages 2106-2117.
Crossref
David R. Strayer, Diane Young & William M. Mitchell. (2020) Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. PLOS ONE 15:10, pages e0240403.
Crossref
Matthew J. Carr, Darren M. Ashcroft, Peter D. White, Nav Kapur & Roger T. Webb. (2019) Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes. Psychological Medicine 50:7, pages 1156-1163.
Crossref
Mateo Cortes Rivera, Claudio Mastronardi, Claudia Silva-Aldana, Mauricio Arcos-Burgos & Brett Lidbury. (2019) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics 9:3, pages 91.
Crossref
Jesús Castro-Marrero, Maria Cleofé Zaragozá, Joan Carles Domingo, Alba Martinez-Martinez, José Alegre & Clemens von Schacky. (2018) Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Prostaglandins, Leukotrienes and Essential Fatty Acids 139, pages 20-24.
Crossref
Stephanie L. McManimen, Damani McClellan, Jamie Stoothoff & Leonard A. Jason. (2018) Effects of unsupportive social interactions, stigma, and symptoms on patients with myalgic encephalomyelitis and chronic fatigue syndrome. Journal of Community Psychology 46:8, pages 959-971.
Crossref
Anthony D. Bram, Kiley A. Gottschalk & William M. Leeds. (2018) Emotional Regulation in Women with Chronic Fatigue Syndrome and Depression: Internal Representations and Adaptive Defenses. Journal of the American Psychoanalytic Association 66:4, pages 701-741.
Crossref
Begoña Ruiz-Núñez, Rabab Tarasse, Emar F. Vogelaar, D. A. Janneke Dijck-Brouwer & Frits A. J. Muskiet. (2018) Higher Prevalence of “Low T3 Syndrome” in Patients With Chronic Fatigue Syndrome: A Case–Control Study. Frontiers in Endocrinology 9.
Crossref
Keith J Geraghty. (2016) ‘PACE-Gate’: When clinical trial evidence meets open data access. Journal of Health Psychology 22:9, pages 1106-1112.
Crossref
Bjørn Grinde. 2017. The Handbook of Stress and Health. The Handbook of Stress and Health 135 146 .
Julian A. G. Glassford. (2017) The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Frontiers in Physiology 8.
Crossref
Emmert Roberts, Simon Wessely, Trudie Chalder, Chin-Kuo Chang & Matthew Hotopf. (2016) Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register. The Lancet 387:10028, pages 1638-1643.
Crossref
Wei-Quan Lin, Meng-Juan Jing, Jie Tang, Jia-Ji Wang, Hui-Shan Zhang, Le-Xin Yuan & Pei-Xi Wang. (2015) Factors Associated with Fatigue among Men Aged 45 and Older: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 12:9, pages 10897-10909.
Crossref
Leonard A. Jason. (2011) Small Wins Matter in Advocacy Movements: Giving Voice to Patients. American Journal of Community Psychology 49:3-4, pages 307-316.
Crossref
David R. Strayer, William A. Carter, Bruce C. Stouch, Staci R. Stevens, Lucinda Bateman, Paul J. Cimoch, Charles W. Lapp, Daniel L. Peterson & William M. Mitchell. (2012) A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome. PLoS ONE 7:3, pages e31334.
Crossref
David J. Newton, Gwen Kennedy, Kenneth K.F. Chan, Chim C. Lang, Jill J.F. Belch & Faisel Khan. (2012) Large and small artery endothelial dysfunction in chronic fatigue syndrome. International Journal of Cardiology 154:3, pages 335-336.
Crossref
Michael Maes & Frank NM Twisk. (2010) Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine 8:1.
Crossref
Wing S. Wong & Richard Fielding. (2010) Prevalence of chronic fatigue among Chinese adults in Hong Kong: A population-based study. Journal of Affective Disorders 127:1-3, pages 248-256.
Crossref
Mary A. Fletcher, Xiao R. Zeng, Kevin Maher, Silvina Levis, Barry Hurwitz, Michael Antoni, Gordon Broderick & Nancy G. Klimas. (2010) Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26. PLoS ONE 5:5, pages e10817.
Crossref
Anil Kumar, Beenta Kumari & Puneet Kumar. (2010) Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress选择性和非选择性环氧合酶抑制剂对慢性压力小鼠模型具有保护作用. Neuroscience Bulletin 26:1, pages 17-27.
Crossref
Peggy Rosati Allen. (2008) Chronic Fatigue Syndrome: Implications for Women and their Health Care Providers During the Childbearing Years. Journal of Midwifery & Women's Health 53:4, pages 289-301.
Crossref
Rodney R. Dietert & Janice M. Dietert. (2008) Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME). Toxicology 247:1, pages 61-72.
Crossref
Vance A. SpenceGwen KennedyJill J. F. BelchAlexander HillFaisel Khan. (2008) Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clinical Science 114:8, pages 561-566.
Crossref
Roumiana S. Boneva, Michael J. Decker, Elizabeth M. Maloney, Jin-Mann Lin, James F. Jones, Helgi G. Helgason, Christine M. Heim, David B. Rye & William C. Reeves. (2007) Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: A population-based study. Autonomic Neuroscience 137:1-2, pages 94-101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.